drug
PORT-77
Phase 2updated 5mo agoby GondolaBio LLC
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying PORT-77
- phase3A Study to Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP)
- phase1Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants
- phase2GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that